Immunotherapy is particularly important in MM, and the main strategies include: immune checkpoint inhibition, in which MM cells evade immune killing by inhibiting T-cell activity through the expression of PD-L1 (13). This evidence concerns the gene CD274 and Miyoshi myopathy.